$0.19
(Market cap
$24 Mln
Revenue (TTM)
$42 Mln
P/E Ratio
--
P/B Ratio
13.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-8 Mln
-
ROE
-7.8 %
-
ROCE
-- %
-
Industry P/E
46.09
-
EV/EBITDA
-2.8
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-2.1
-
Face value
--
-
Shares outstanding
11,936,400
5 Years Aggregate
CFO
$-63.18 Mln
EBITDA
$-62.87 Mln
Net Profit
$-103.06 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Aziyo Biologics Inc (AZYO)
| -61.4 | 20.4 | -2.4 | -80.0 | -46.6 | -- | -- |
|
BSE Sensex*
| -11.5 | -4.6 | 1.3 | -7.6 | 4.0 | 5.1 | 10.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2022
|
2021
|
|---|---|---|
|
Aziyo Biologics Inc (AZYO)
| -32.5 | -53.8 |
|
S&P Small-Cap 600
| -17.4 | 25.3 |
|
BSE Sensex
| 4.4 | 22.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Aziyo Biologics Inc (AZYO)
|
1.6 | 24.2 | 42.1 | -33.8 | -44.7 | -- | -- | 13.3 |
| 66.4 | 8,162.7 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.0 | |
| 14.9 | 10,125.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.8 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.4 | |
| 53.6 | 8,913.0 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 170.4 | 10,637.8 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 15.3 | |
| 100.4 | 6,590.6 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.2 | 5.0 | |
| 317.8 | 12,649.5 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.3 | 8.3 | |
| 164.7 | 9,458.6 | 785.1 | 41.5 | 9.9 | 2 | 232.8 | 4.6 | |
| 27.6 | 12,007.0 | 6,164.0 | 625.0 | 13.0 | 11.8 | 19.5 | 2.3 |
Shareholding Pattern
View DetailsAbout Aziyo Biologics Inc (AZYO)
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative products to address the device protection, women's health, orthobiologics, cardiovascular, and soft tissue reconstruction markets. It offers CanGaroo... that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. In addition, it offers Fiber VBM, ViBone, and OsteGro V that are human tissue-derived bone allografts designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. Further, the company provides contract manufacturing services for various products to corporate customers. It sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland. Read more
-
Exec. Chairman
Mr. Kevin L. Rakin M.B.A, M.S.
-
Exec. Chairman
Mr. Kevin L. Rakin M.B.A, M.S.
-
Headquarters
Silver Spring, MD
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Aziyo Biologics Inc (AZYO)
What is the current share price of Aziyo Biologics Inc (AZYO) Today?
The share price of Aziyo Biologics Inc (AZYO) is $1.64 (NASDAQ) as of 08-Nov-2023 09:30 EDT. Aziyo Biologics Inc (AZYO) has given a return of -46.6% in the last 3 years.
What is the current PB & PE ratio of Aziyo Biologics Inc (AZYO)?
Since, TTM earnings of Aziyo Biologics Inc (AZYO) is negative, P/E ratio is not available.
The P/B ratio of Aziyo Biologics Inc (AZYO) is 13.34 times as on 08-Nov-2023, a 253 premium to its peers’ median range of 3.78 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-1.87 |
-12.22 |
2021 |
-2.81 |
5.17 |
2020 |
-6.39 |
6.69 |
2019 |
-- |
-- |
2018 |
-- |
-- |
What is the 52 Week High and Low of Aziyo Biologics Inc (AZYO)?
The 52-week high and low of Aziyo Biologics Inc (AZYO) are Rs -- and Rs -- as of 11-Sep-2026.
What is the market cap of Aziyo Biologics Inc (AZYO)?
Aziyo Biologics Inc (AZYO) has a market capitalisation of $ 24 Mln as on 08-Nov-2023. As per SEBI classification, it is a Small Cap company.
Should I invest in Aziyo Biologics Inc (AZYO)?
Before investing in Aziyo Biologics Inc (AZYO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.